Opana ER Maker to Stop Marketing Drug as Crush-Resistant Under NY Settlement - Partnership for Drug-Free Kids

Opana ER Maker to Stop Marketing Drug as Crush-Resistant Under NY Settlement - Partnership for Drug-Free Kids: The maker of the long-acting painkiller Opana ER has agreed to stop marketing the drug as crush-resistant, under a settlement with New York State. The company also agreed to accurately describe the risk of addiction to the drug, Reuters reports.